The National Advisory Committee on Immunization (NACI) announces new recommendations for individuals who had the AstraZeneca/COVISHIELD vaccine as their first dose and states it “is now preferred” that an mRNA vaccine (Pfizer-BioNTech or Moderna) be used for their second dose